Allostery Investments LP
Follow13F filer, CIK 1978599, Stamford, CT
Allostery Investments LP reported $0 across 1 holding for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001013594-25-001424
- Period
- 2025-09-30
- Reported value
- $0
- Holdings
- 1
- Top 10 weight
- New
- 1
- Sold out
- 20
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ABVXexited | -167,350 | -$1.28M |
| AKROexited | -22,500 | -$1.2M |
| AMLXexited | -120,119 | -$770K |
| CNTAexited | -52,500 | -$690K |
| EOLSexited | -60,000 | -$553K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2025
Share positions as resolved from 13F-HR 0001013594-25-001424, largest first. % of portfolio is the value over $0, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| 00 | 0 | $0 | new | Value filed as zero, left out of ratios.Amount filed as zero, left out of ratios. |
Sold out in Q3 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| ABVXABIVAX SA | 167,350 | $1.28M | shares |
| AKROAKERO THERAPEUTICS INC | 22,500 | $1.2M | shares |
| AMLXAMYLYX PHARMACEUTICALS INC | 120,119 | $770K | shares |
| CNTACENTESSA PHARMACEUTICALS PLC | 52,500 | $690K | shares |
| EOLSEVOLUS INC | 60,000 | $553K | shares |
| RZLTREZOLUTE INC | 119,294 | $532K | shares |
| MERUS N VMERUS N V | 9,000 | $473K | shares |
| KALVKALVISTA PHARMACEUTICALS INC | 40,000 | $452K | shares |
| FULCFULCRUM THERAPEUTICS INC | 40,353 | $278K | shares |
| APGEAPOGEE THERAPEUTICS INC | 6,000 | $261K | shares |
| VERONA PHARMA PLCVERONA PHARMA PLC | 2,500 | $236K | shares |
| TNGXTANGO THERAPEUTICS INC | 40,000 | $205K | shares |
| BBIOBRIDGEBIO PHARMA INC | 4,000 | $173K | shares |
| CYTKCYTOKINETICS INC | 5,000 | $165K | shares |
| Tourmaline Bio IncTourmaline Bio Inc | 9,356 | $150K | shares |
| LEGNLEGEND BIOTECH CORP | 4,000 | $142K | shares |
| NKTRNEKTAR THERAPEUTICS | 4,000 | $103K | shares |
| PROMIS NEUROSCIENCES INCPROMIS NEUROSCIENCES INC | 155,720 | $76.3K | shares |
| ACLXARCELLX INC | 1,000 | $65.8K | shares |
| AVTXAVALO THERAPEUTICS INC | 9,000 | $44.9K | shares |
How Q3 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001013594-25-001424 | base | 2025-11-14 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-25-001424 | Quarter ended 2025-09-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001013594-25-001022 | Quarter ended 2025-06-30 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001013594-25-000654 | Quarter ended 2025-03-31 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001013594-25-000290 | Quarter ended 2024-12-31 | 2025-02-14 | acceptance time not in the bulk data set |